Pharma major Wockhardt has advanced 4% on getting tentative nod from US FDA.
The scrip opened at Rs 180 and touched a high of Rs 186. The scrip is now trading at Rs 183, up 4% from its previous close. The counter has clocked volumes of 1.26 lakhs on the BSE as compared to the two-week daily average traded volumes of 0.84 lakh shares on the BSE.
The company has got the approval from the US drug regulator to market 'Memantine HCl' tablets, used for the treatment of Alzheimer's disease and dementia.